Takahiro Masuda

SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice

Volker Vallon, Maria Gerasimova, Michael Rose et al. · American Journal of Physiology-Renal Physiology · 2013 · 477 citations

Medicine, Nephrology, Pharmacology +17

Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia

Timo Rieg, Takahiro Masuda, Maria Gerasimova et al. · American Journal of Physiology-Renal Physiology · 2013 · 303 citations

Pharmacy, Biochemistry, Pharmacology +16

Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice

Timo Rieg, Maria Gerasimova, Fiona Murray et al. · American Journal of Physiology-Renal Physiology · 2012 · 158 citations

Medicine, Endocrinology, Pharmacology +16

Osmotic diuresis by SGLT2 inhibition stimulates vasopressin‐induced water reabsorption to maintain body fluid volume

Takahiro Masuda, Shigeaki Muto, Keiko Fukuda et al. · Physiological Reports · 2020 · 132 citations · Full text

Pharmacy, Endocrinology, Physiology +17

Effects of the sodium‐glucose cotransporter 2 inhibitor dapagliflozin on fluid distribution: A comparison study with furosemide and tolvaptan

Ken Ohara, Takahiro Masuda, Takuya Murakami et al. · Nephrology · 2018 · 81 citations

Pharmacy, Pharmacology, Pharmacotherapy +17